A Daily Network publication
Explore the network
Wealth Advisor Daily
The advisor's edition — practice, portfolio, and the book.
Wednesday, October 7, 2026The Morning Brief →Sign in

Who holds ORKAOruka Therapeutics

11 funds on our shelf carry Oruka Therapeutics — heaviest hand: XBI at 1.37% of its book.

FundWeightFund assetsShares held
XBIState Street SPDR S&P Biotech ETFINDEX1.37%$10.3B1,549,262
DWASInvesco Dorsey Wright SmallCap Momentum ETFINDEX1.24%$411M60,471
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.37%$112M4,720
IBBiShares Biotechnology ETFINDEX0.35%$10.6B444,963
VTWGVanguard Russell 2000 Growth ETFINDEX0.29%$1B54,990
IWOiShares Russell 2000 Growth ETFINDEX0.28%$14.4B472,492
VFMOVanguard U.S. Momentum Factor ETFINDEX0.17%$646M39,118
VTWOVanguard Russell 2000 ETFINDEX0.15%$9.9B289,515
IWMiShares Russell 2000 ETFINDEX0.14%$79.3B1,316,575
RSSLGlobal X Russell 2000 ETFINDEX0.14%$1.5B23,844
VHTVanguard Health Care Index FundINDEX0.05%$19B116,963

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

Every weekday · 6:30 a.m. ET

The Morning Brief

The latest from Wealth Advisor Daily, in your inbox every weekday. Free.